A new visit to the opening of the center: GALACTIC-1 phase IIb clinical trial involving patients with Idiopathic Pulmonary Fibrosis, sponsored by the pharmaceutical company Galecto Bayotek AB, Denmark
A new visit to the opening of the center: GALACTIC-1 phase IIb clinical trial involving patients with Idiopathic Pulmonary Fibrosis, sponsored by the pharmaceutical company Galecto Bayotek AB, Denmark